|
Where to Find? .....
DHHS Labs
The current list of DHHS certified labs is published the first week of
each month and is printed in the Federal Register under the Substance Abuse
and Mental Health Services Administration (SAMHSA) heading. Only those labs
certified can be used for FTA drug testing. The list should be checked
monthly as new labs are being added and others are being removed.
Website location:
http://
www.workplace.samhsa.gov/
ResourceCenter/lablist.htm
To verify the certification status of a laboratory, DHHS has established
a telephone HELPLINE (800) 843-4971.
The information presented on this page should be used to
update Chapters 9 of the revised Implementation
Guidelines. |
FTA Seeking Info on Recidivism The
FTA drug and alcohol regulation (49 CFR Part 655) requires that all
covered employers include the consequences for a positive test result or
test refusal in their policy. At a minimum, the regulation requires all
safety-sensitive employees who violate the rule be immediately removed
from their position, and be referred for evaluation by a Substance Abuse
Professional (SAP). Any further action (e.g., suspension, termination)
taken against the employee is left up to the discretion of the employer,
consistent with the law.
An employer’s decision to be zero tolerant, second chance or a
hybrid of the two is based on many factors including collective
bargaining agreements, investment in personnel development including
training costs, workforce availability, employer size, liability
concerns, corporate philosophy, and anticipated recidivism rates, to
name a few. This decision is complicated and has far reaching
implications. Of all the factors considered, as an industry, we know the
least factual information about recidivism, leaving decision makers to
make their decisions based on speculation and limited knowledge.
An employer’s SAP or local rehabilitation and treatment facilities
may provide insights into recidivism rates that correspond to specific
programs, but little is known about the experience of transit systems
that are covered by the FTA drug and alcohol regulation. FTA has
determined that this information would be beneficial to the transit
industry to aid employers making informed decisions. Since most covered
employers have had their testing programs, return-to-duty, and follow up
testing procedures in place for over ten years, FTA believes that there
is now sufficient experience from which to draw.
Consequently, in the first week of February, FTA will solicit
information on recidivism experience through an electronic questionnaire
administered via the FTA website. All employers in the FTA drug and
alcohol program database will be sent a notice with directions on how to
access and complete the questionnaire. The questionnaire will contain
questions on the following topics:
- System information (i.e., size, geographic location, type of
service);
- Contractor versus directly operated service;
- Unionization;
- Employer’s type of policy (e.g., zero tolerance, second chance,
other);
- Consequences for non-negative test results;
- Demographics of employee;
- SAP evaluation process and timeline;
- Extent, scope and frequency of rehabilitation, treatment and
aftercare programs utilized;
- Return-to-duty process;
- Follow-up testing procedures including duration and frequency;
- Numbers of employees provided a second chance and percent having
a second non-negative test results;
- Experience rates by classification of employee, classification
of drug and/or alcohol, treatment program, and frequency and
duration of follow-up testing program;
- Characteristics of second positive test (i.e., span of time
between
first and second positive, same or different substance, extent of
participation in after care program);
- Other relevant information
The results of the study will be summarized in the next
edition of this newsletter. In addition, the results will be presented
at the 2006 FTA Drug and Alcohol Program National Conference in Las
Vegas (see article on page one of this newsletter).
For more information regarding this data collection effort, please
contact FTA’s Drug and Alcohol Program Manager, Jerry Powers or the
newsletter editor at RLS & Associates, Inc. at
rls@rlsandassoc.com. |